Filtros : "Financiamento Sichuan Science and Technology Program" "IQ-QBQ" Limpar

Filtros



Limitar por data


  • Fonte: MedComm. Unidade: IQ

    Assuntos: RECEPTORES, ADENOSINA, TRANSTORNOS COGNITIVOS

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ILLES, Peter et al. Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy. MedComm, v. 6, p. 1-23 art. e70177, 2025Tradução . . Disponível em: https://dx.doi.org/10.1002/mco2.70177. Acesso em: 16 nov. 2025.
    • APA

      Illes, P., Rubini, P., Ulrich, H., Yin, H. -Y., & Tang, Y. (2025). Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy. MedComm, 6, 1-23 art. e70177. doi:10.1002/mco2.70177
    • NLM

      Illes P, Rubini P, Ulrich H, Yin H-Y, Tang Y. Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy [Internet]. MedComm. 2025 ; 6 1-23 art. e70177.[citado 2025 nov. 16 ] Available from: https://dx.doi.org/10.1002/mco2.70177
    • Vancouver

      Illes P, Rubini P, Ulrich H, Yin H-Y, Tang Y. Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy [Internet]. MedComm. 2025 ; 6 1-23 art. e70177.[citado 2025 nov. 16 ] Available from: https://dx.doi.org/10.1002/mco2.70177
  • Fonte: Frontiers Pharmacology. Unidade: IQ

    Assuntos: SISTEMA NERVOSO CENTRAL, DOENÇAS DO SISTEMA NERVOSO

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TANG, Yong et al. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial]. Frontiers Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. Disponível em: https://dx.doi.org/10.3389/fphar.2023.1355286. Acesso em: 16 nov. 2025. , 2024
    • APA

      Tang, Y., Rubini, P., Sperlagh, B., & Ulrich, H. (2024). Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial]. Frontiers Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. doi:10.3389/fphar.2023.1355286
    • NLM

      Tang Y, Rubini P, Sperlagh B, Ulrich H. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] [Internet]. Frontiers Pharmacology. 2024 ; 14 1-2 art. 1355286.[citado 2025 nov. 16 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1355286
    • Vancouver

      Tang Y, Rubini P, Sperlagh B, Ulrich H. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] [Internet]. Frontiers Pharmacology. 2024 ; 14 1-2 art. 1355286.[citado 2025 nov. 16 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1355286
  • Fonte: Drug Resistance Updates. Unidade: IQ

    Assuntos: NEOPLASIAS, PURINAS, PROLIFERAÇÃO CELULAR

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JIA, Wenhui et al. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies. Drug Resistance Updates, v. 70, p. 1-13 art. 100988, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.drup.2023.100988. Acesso em: 16 nov. 2025.
    • APA

      Jia, W., Huang, Z., Zhou, L., Liou, Y. -C., Virgilio, F. D., Ulrich, H., et al. (2023). Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies. Drug Resistance Updates, 70, 1-13 art. 100988. doi:10.1016/j.drup.2023.100988
    • NLM

      Jia W, Huang Z, Zhou L, Liou Y-C, Virgilio FD, Ulrich H, Peter I, Zhang W, Huang C, Tang Y. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies [Internet]. Drug Resistance Updates. 2023 ; 70 1-13 art. 100988.[citado 2025 nov. 16 ] Available from: https://doi.org/10.1016/j.drup.2023.100988
    • Vancouver

      Jia W, Huang Z, Zhou L, Liou Y-C, Virgilio FD, Ulrich H, Peter I, Zhang W, Huang C, Tang Y. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies [Internet]. Drug Resistance Updates. 2023 ; 70 1-13 art. 100988.[citado 2025 nov. 16 ] Available from: https://doi.org/10.1016/j.drup.2023.100988
  • Fonte: Neuroscience Bulletin. Unidade: IQ

    Assuntos: AÇÚCAR, CÉREBRO, RECEPTORES

    PrivadoAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAO, Xin et al. A Neural circuit for gut-induced sugar preference. Neuroscience Bulletin, v. 37, n. 5 p. 754–756, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12264-021-00692-x. Acesso em: 16 nov. 2025.
    • APA

      Cao, X., Yin, H. -Y., Ulrich, H., Semyanov, A., & Tang, Y. (2021). A Neural circuit for gut-induced sugar preference. Neuroscience Bulletin, 37( 5 p. 754–756). doi:10.1007/s12264-021-00692-x
    • NLM

      Cao X, Yin H-Y, Ulrich H, Semyanov A, Tang Y. A Neural circuit for gut-induced sugar preference [Internet]. Neuroscience Bulletin. 2021 ; 37( 5 p. 754–756):[citado 2025 nov. 16 ] Available from: https://doi.org/10.1007/s12264-021-00692-x
    • Vancouver

      Cao X, Yin H-Y, Ulrich H, Semyanov A, Tang Y. A Neural circuit for gut-induced sugar preference [Internet]. Neuroscience Bulletin. 2021 ; 37( 5 p. 754–756):[citado 2025 nov. 16 ] Available from: https://doi.org/10.1007/s12264-021-00692-x

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2025